Do Pharma CEOs Have the Prescription for a Net Zero World?

Ahead of COP28, the UN’s climate conference, we explore the unique ways public-private partnerships help achieve sustainability goals. Lars Fruergaard Jørgensen, CEO of Novo Nordisk; Pascal Soriot, CEO of AstraZeneca; and Christine O’Brien, lead for BCG’s climate and sustainability practice in health care, discuss the projects and success of the Sustainable Markets Initiative Health Systems Task Force.

The Task Force brings together global health leaders to enhance individual, societal, and planetary health. Together, they have launched sector-first commitments, actions, and recommendations to accelerate the delivery of net zero, patient-centric health systems.

 Learn More: 

https://www.sustainable-markets.org/taskforces/health-systems-taskforce/  

For more about Pascal: https://www.astrazeneca.com/our-company/leadership.html#

For more about Lars: https://www.novonordisk.com/about/executive-management/lars-fruergaard-jorgensen.html

For more about Christine: https://on.bcg.com/3R9xbSJ)

https://on.bcg.com/47KDWQp

This podcast uses the following third-party services for analysis:

Chartable - https://chartable.com/privacy